论文部分内容阅读
Aim:Hepatic glycogen phosphorylase (GP) and glucose-6-phosphatase (G6Pase) play an important role in the control of blood glucose homeostasis and are proposed to be potential targets for anti-diabetic drugs.Geniposide is an iridoid gluco-side extracted from Gardenia jasminoides Ellis fruits and has been reported to have a hypoglycemic effect.However,little is known about the biochemical mechanisms by which geniposide regulates hepatic glucose-metabolizing enzymes.The pres-ent study investigates whether the hypoglycemic effect of geniposide is mediated by GP or G6Pase.Methods: Type 2 diabetic mice,induced by a high-fat diet and streptozotocin injection,were treated with or without geni-poside for 2 weeks.Blood glucose levels were monitored by a glucometer.Insulin concentrations were analyzed by the ELISA method.Total cholesterol (TC) and triglyceride (TG) levels were measured using LabassayTM kits.Activities of hepatic GP and G6Pase were measured by glucose-6-phosphate dehydrogenase-coupled reaction.Real-time RT-PCR and Weste blotting were used to determine the mRNA and protein levels of both enzymes.Results: Geniposide (200 and 400 mg/kg) significantly decreased the blood glucose,insulin and TG levels in diabetic mice in a dose-dependent manner.This compound also decreased the expression of GP and G6Pase at mRNA and immunoreac-tive protein levels,as well as enzyme activity.Conclusion: Geniposide is an effective hypoglycemic agent in diabetic mice.The hypoglycemic effect of this compound may be mediated,at least in part,by inhibiting the GP and G6Pase activities.